Healthcare DIVE August 22, 2019
As recently as a year-and-a-half ago, the chief executive of diabetes tech nonprofit Tidepool wouldn’t have predicted a collaboration with Medtronic, he told MedTech Dive in an interview.
During the diabetes research community’s biggest gathering of the year, the largest pure medtech in the world announced it would support Tidepool’s effort to turn the existing, open source “do-it-yourself” loop algorithm — used by some people with diabetes in an attempt to automate their insulin delivery — into a fully interoperable, FDA-regulated, App Store offering.
“We are all a bit in (good) shock that this is happening,” Tidepool CEO Howard Look tweeted following announcement of the partnership with the medtech giant past June.
The Tidepool Loop app is being designed to...